When we integrated this data set with its corresponding patient-matched normal tissue data sets (Supplemental Figure 5A), we observed increases in SELENOP expression from normal crypt stem cells to ASCs to MSS cancer cells (Figure 2C). The gene discussed is SELENOP; the disease is cancer.